99 related articles for article (PubMed ID: 12396736)
1. Effect of chemical modification on the pharmacokinetics and biodistribution of carboxymethyl dextran as a drug carrier.
Lee SD; Lim SJ; Kim CK
Drug Deliv; 2002; 9(3):187-93. PubMed ID: 12396736
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting.
Nishikawa M; Kamijo A; Fujita T; Takakura Y; Sezaki H; Hashida M
Pharm Res; 1993 Sep; 10(9):1253-61. PubMed ID: 7694271
[TBL] [Abstract][Full Text] [Related]
3. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
4. Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran.
Hashida M; Atsumi R; Nishida K; Nakane S; Takakura Y; Sezaki H
J Pharmacobiodyn; 1990 Jul; 13(7):441-7. PubMed ID: 1705289
[TBL] [Abstract][Full Text] [Related]
5. Development and in vivo characterization of a novel peptide drug delivery system providing extended plasma half life.
Shahnaz G; Iqbal J; Rahmat D; Perera G; Laffleur F; Rossi D; Bernkop-Schnürch A
J Control Release; 2012 Feb; 157(3):375-82. PubMed ID: 21986100
[TBL] [Abstract][Full Text] [Related]
6. [Magnetic drug delivery system--adriamycin-carboxymethyl dextran magnetic nanoparticles].
Shi K; Li C; He B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Mar; 17(1):21-4. PubMed ID: 10879185
[TBL] [Abstract][Full Text] [Related]
7. Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of (14)C-labeled quaternary ammonium-glucosamine conjugates.
Giraud I; Rapp M; Maurizis JC; Madelmont JC
Bioconjug Chem; 2000; 11(2):212-8. PubMed ID: 10725098
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of 111In-labeled uricase conjugated with charged dextrans and polyethylene glycol.
Fujita T; Yasuda Y; Takakura Y; Hashida M; Sezaki H
J Pharmacobiodyn; 1991 Nov; 14(11):623-9. PubMed ID: 1725532
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers.
Gaowa A; Horibe T; Kohno M; Tabata Y; Harada H; Hiraoka M; Kawakami K
Eur J Pharm Biopharm; 2015 May; 92():228-36. PubMed ID: 25801495
[TBL] [Abstract][Full Text] [Related]
10. Carboxymethyl dextran-based hypoxia-responsive nanoparticles for doxorubicin delivery.
Son S; Rao NV; Ko H; Shin S; Jeon J; Han HS; Nguyen VQ; Thambi T; Suh YD; Park JH
Int J Biol Macromol; 2018 Apr; 110():399-405. PubMed ID: 29133095
[TBL] [Abstract][Full Text] [Related]
11. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition.
Zhang X; Mehvar R
J Pharm Sci; 2001 Dec; 90(12):2078-87. PubMed ID: 11745766
[TBL] [Abstract][Full Text] [Related]
12. Extending insulin action in vivo by conjugation to carboxymethyl dextran.
Baudys M; Letourneur D; Liu F; Mix D; Jozefonvicz J; Kim SW
Bioconjug Chem; 1998; 9(2):176-83. PubMed ID: 9548532
[TBL] [Abstract][Full Text] [Related]
13. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
[TBL] [Abstract][Full Text] [Related]
14. The protein-binding and drug release properties of macromolecular conjugates containing daptomycin and dextran.
Muangsiri W; Kirsch LE
Int J Pharm; 2006 Jun; 315(1-2):30-43. PubMed ID: 16546333
[TBL] [Abstract][Full Text] [Related]
15. Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats.
Mehvar R; Robinson MA; Reynolds JM
J Pharm Sci; 1994 Oct; 83(10):1495-9. PubMed ID: 7533835
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the T cell response to beta-lactoglobulin by conjugation with carboxymethyl dextran.
Kobayashi K; Yoshida T; Takahashi K; Hattori M
Bioconjug Chem; 2003; 14(1):168-76. PubMed ID: 12526706
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes.
Gutiérrez Millán C; Zarzuelo Castañeda A; González López F; Sayalero Marinero ML; Lanao JM
J Antimicrob Chemother; 2008 Feb; 61(2):375-81. PubMed ID: 18096557
[TBL] [Abstract][Full Text] [Related]
18. Disposition characteristics of macromolecules in tumor-bearing mice.
Takakura Y; Fujita T; Hashida M; Sezaki H
Pharm Res; 1990 Apr; 7(4):339-46. PubMed ID: 1694582
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tissue distribution of cisplatin and conjugates of cisplatin with carboxymethyldextran and A5B7 monoclonal antibody in CD1 mice.
McIntosh DP; Cooke RJ; McLachlan AJ; Daley-Yates PT; Rowland M
J Pharm Sci; 1997 Dec; 86(12):1478-83. PubMed ID: 9423164
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: influence of technological factors.
Beloqui A; Solinís MA; Delgado A; Evora C; del Pozo-Rodríguez A; Rodríguez-Gascón A
Eur J Pharm Biopharm; 2013 Jun; 84(2):309-14. PubMed ID: 23461861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
